Treatment efficacy of ribociclib or palbociclib plus letrozole in hormone receptor-positive/HER2-negative metastatic breast cancer

Tarih

Yazarlar

Seyyar, Mustafa

Bayram, Ertugrul

Demirel, Burcin Cakan

Baytemur, Naziyet Kose

Yayınevi

FUTURE MEDICINE LTD

Anahtar kelimeler

CDK 4, 6 inhibitors, HER2\\-negative metastatic breast cancer, HR\\-positive, letrozole

URI

https://openaccess.acibadem.edu.tr/handle/11443/6454

Koleksiyonlar

Tam öğe sayfası